US Drug Recall Register
Class III · Low risk Terminated Initiated Jul 6, 2020 (6 years ago)

Clonazepam Orally Disintegrating Tablets

Class III — Low risk. Unlikely to cause harm, but violates FDA regulations.

Why it was recalled

Cross contamination with other products - OOS discovered during routine stability testing for highest unknown impurity later identified as clozapine

What was recalled

Clonazepam Orally Disintegrating Tablets, USP, 0.125 mg, 60-count bottle, Rx only, Mfg by: Sun Pharmaceutical Industries, Inc. Cranbury, NJ 08512, NDC 57664-783-86

Recalling firm
Sun Pharmaceutical Industries INC
NDC code
57664-783-86
Origin
NJ, United States
Initiated by
Voluntary: Firm initiated
FDA recall number
D-1445-2020

What should you do? A recall doesn't always mean your specific bottle is affected - it often applies to certain lots only. Check the lot number on your package against the FDA notice, and talk to your pharmacist before stopping any medication.

Other Clonazepam recalls

See all
Class I · High risk Ongoing

Clonazepam Orally Disintegrating Tablets

Reason Labeling: Label Error on Declared Strength; Some cartons were incorrectly labeled. The blister strips inside the product carton reflect the correct strength.

Endo USA, Inc. D-0181-2025
Class I · High risk Ongoing

Clonazepam Orally Disintegrating Tablets

Reason Labeling: Label Error on Declared Strength; Some cartons were incorrectly labeled. The blister strips inside the product carton reflect the correct strength.

Endo USA, Inc. D-0180-2025
Class I · High risk Ongoing

Clonazepam Orally Disintegrating Tablets

Reason Labeling: Label Error on Declared Strength; Some cartons were incorrectly labeled. The blister strips inside the product carton reflect the correct strength.

Endo USA, Inc. D-0179-2025
Class I · High risk Ongoing

Clonazepam Orally Disintegrating Tablet

Reason Labeling: Label Error on Declared Strength; Some cartons were incorrectly labeled. The blister strips inside the product carton reflect the correct strength.

Endo USA, Inc. D-0178-2025
Class I · High risk Terminated

Clonazepam Orally Disintegrating Tablets

Reason Labeling: Label Error on Declared Strength; Some cartons were incorrectly labeled as 0.125 mg instead of 0.25 mg. The blister strips inside the product carton reflect the correct strength of 0.25 mg.

Endo Pharmaceuticals, Inc. NDC 49884-306-02 D-0622-2024